Mutations in SF3B1 gene are selected independently on ATM/TP53 status and reduce the time to first treatment in CLL patients.

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	HLOŽKOVÁ Michaela FIGULOVÁ Jana NAVRKALOVÁ Veronika MALČÍKOVÁ Jitka ŠMARDOVÁ Jana TOM Nikola BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří POSPÍŠILOVÁ Šárka TRBUŠEK Martin
Year of publication	2016
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Related projects:	Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit III